DekaBank Deutsche Girozentrale’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $340K | Hold |
11,300
| – | – | ﹤0.01% | 1044 |
|
|
2025
Q1 | $388K | Hold |
11,300
| – | – | ﹤0.01% | 1008 |
|
|
2024
Q4 | $577K | Hold |
11,300
| – | – | ﹤0.01% | 973 |
|
|
2024
Q3 | $570K | Hold |
11,300
| – | – | ﹤0.01% | 988 |
|
|
2024
Q2 | $492K | Hold |
11,300
| – | – | ﹤0.01% | 1009 |
|
|
2024
Q1 | $498K | Hold |
11,300
| – | – | ﹤0.01% | 1002 |
|
|
2023
Q4 | $402K | Hold |
11,300
| – | – | ﹤0.01% | 1085 |
|
|
2023
Q3 | $333K | Hold |
11,300
| – | – | ﹤0.01% | 1102 |
|
|
2023
Q2 | $200K | Hold |
11,300
| – | – | ﹤0.01% | 1163 |
|
|
2023
Q1 | $177K | Hold |
11,300
| – | – | ﹤0.01% | 1198 |
|
|
2022
Q4 | $206K | Hold |
11,300
| – | – | ﹤0.01% | 1214 |
|
|
2022
Q3 | $214K | Hold |
11,300
| – | – | ﹤0.01% | 1216 |
|
|
2022
Q2 | $198K | Hold |
11,300
| – | – | ﹤0.01% | 1189 |
|
|
2022
Q1 | $215K | Buy |
11,300
+1,000
| +10% | +$19K | ﹤0.01% | 1196 |
|
|
2021
Q4 | $276K | Buy |
10,300
+300
| +3% | +$8.04K | ﹤0.01% | 1211 |
|
|
2021
Q3 | $205K | Hold |
10,000
| – | – | ﹤0.01% | 1204 |
|
|
2021
Q2 | $187K | Hold |
10,000
| – | – | ﹤0.01% | 1230 |
|
|
2021
Q1 | $154K | Hold |
10,000
| – | – | ﹤0.01% | 1235 |
|
|
2020
Q4 | $129K | Buy |
+10,000
| New | +$129K | ﹤0.01% | 1248 |
|
|
2019
Q1 | – | Sell |
-11,000
| Closed | -$330K | – | 1209 |
|
|
2018
Q4 | $330K | Buy |
+11,000
| New | +$330K | ﹤0.01% | 899 |
|